Staging β-amyloid pathology with amyloid positron emission tomography

July 17, 2019

What The Study Did: This multicenter study used in vivo β-amyloid cerebrospinal fluid, a biomarker of Alzheimer disease, and positron emission tomography findings to track progression of Alzheimer disease over six years among study participants.

Authors: Niklas Mattsson, M.D., Ph.D., and Oskar Hansson, M.D., Ph.D., of Lund University in Malmo, Sweden, are the corresponding authors.

(doi:10.1001/jamaneurol.2019.2214)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Media Advisory: This article is being released to coincide with the Alzheimer's Association International Conference. The full study and related articles also being released to coincide with the event are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jamaneurology/fullarticle/2738356?guestAccessKey=76eb6e58-8821-46cf-978a-2d91f3251e16&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071719

JAMA Neurology

Related Alzheimer Disease Articles from Brightsurf:

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Uncovering Alzheimer's disease
Characterized by a buildup of amyloid plaques in the brain, Alzheimer's is an irreversible disease that leads to memory loss and a decrease in cognitive function.

Viewpoint: Could disease pathogens be the dark matter behind Alzheimer's disease?
In a lively discussion appearing in the Viewpoint section of the journal Nature Reviews Neurology, Ben Readhead, a researcher in the ASU-Banner Neurodegenerative Disease Research Center at the Biodesign Institute joins several distinguished colleagues to discuss the idea that bacteria, viruses or other infectious pathogens may play a role in Alzheimer's disease.

Coordination chemistry and Alzheimer's disease
It has become evident recently that the interactions between copper and amyloid-β neurotoxically impact the brain of patients with Alzheimer's disease.

How Alzheimer's disease spreads through the brain
Tau can quickly spread between neurons but is not immediately harmful, according to research in mouse neurons published in JNeurosci.

A protective factor against Alzheimer's disease?
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the Institute for Stroke and Dementia Research (ISD) at the University Hospital of the Ludwig-Maximilians-Universität (LMU) in Munich have found that a protein called TREM2 could positively influence the course of Alzheimer's disease.

An alternate theory for what causes Alzheimer's disease
Alzheimer's disease, the most common cause of dementia among the elderly, is characterized by plaques and tangles in the brain, with most efforts at finding a cure focused on these abnormal structures.

Alzheimer's: How does the brain change over the course of the disease?
What changes in the brain are caused by Alzheimer's disease?

Possible pathway to new therapy for Alzheimer's disease
Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD).

Promising novel treatment against Alzheimer disease
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model.

Read More: Alzheimer Disease News and Alzheimer Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.